Identifying Predominant Causes of Death Among Hospitalized COVID-19 Patients During Poland\'s Second and Third Waves DOI Creative Commons

Irina Niecwietajewa,

Michał Frączek,

Maria Mroczkowska

et al.

Medical Science Monitor, Journal Year: 2023, Volume and Issue: 29

Published: Sept. 12, 2023

BACKGROUND Number of confirmed COVID-19 deaths per million population in Poland between November 2020 and May 2021 was one the largest Europe. This retrospective study conducted at a single center 2021to evaluate morbidity mortality rates 581 patients hospitalized with COVID-19. MATERIAL AND METHODS A single-center dedicated hospital from November, to May, 2021. The data were analyzed. Multimorbidity assessed using Charlson Comorbidity Index, including chronic kidney, respiratory, cardiovascular diseases, diabetes mellitus, cancer, dementia. observation period covered admission for severe until discharge or death. Diagnosis by quantitative reverse transcription polymerase chain reaction test. Statistical analysis carried out IBM SPSS Statistics program. RESULTS rate 35% all admitted patients. Lung damage cause death 60%, bacterial superinfection 26%, arterial thrombosis thromboembolism 9%, heart failure 5% chi-square test showed significant relationship sex related pneumonia ventilator-associated (VAP). CONCLUSIONS findings this supports other countries that 2021, before SARS-CoV-2 vaccination programs fully implemented effective medications antiviral agents developed, had high mortality.

Language: Английский

Identifying Predominant Causes of Death Among Hospitalized COVID-19 Patients During Poland\'s Second and Third Waves DOI Creative Commons

Irina Niecwietajewa,

Michał Frączek,

Maria Mroczkowska

et al.

Medical Science Monitor, Journal Year: 2023, Volume and Issue: 29

Published: Sept. 12, 2023

BACKGROUND Number of confirmed COVID-19 deaths per million population in Poland between November 2020 and May 2021 was one the largest Europe. This retrospective study conducted at a single center 2021to evaluate morbidity mortality rates 581 patients hospitalized with COVID-19. MATERIAL AND METHODS A single-center dedicated hospital from November, to May, 2021. The data were analyzed. Multimorbidity assessed using Charlson Comorbidity Index, including chronic kidney, respiratory, cardiovascular diseases, diabetes mellitus, cancer, dementia. observation period covered admission for severe until discharge or death. Diagnosis by quantitative reverse transcription polymerase chain reaction test. Statistical analysis carried out IBM SPSS Statistics program. RESULTS rate 35% all admitted patients. Lung damage cause death 60%, bacterial superinfection 26%, arterial thrombosis thromboembolism 9%, heart failure 5% chi-square test showed significant relationship sex related pneumonia ventilator-associated (VAP). CONCLUSIONS findings this supports other countries that 2021, before SARS-CoV-2 vaccination programs fully implemented effective medications antiviral agents developed, had high mortality.

Language: Английский

Citations

1